HomeEVOK • NASDAQ
Evoke Pharma Inc
Follow
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 3.31M | 97.40% |
Operating expense | 4.38M | 25.07% |
Net income | -1.19M | 39.98% |
Net profit margin | -36.05 | 69.60% |
Earnings per share | -0.77 | 89.12% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 13.60M | 186.88% |
Total assets | 17.52M | 147.84% |
Total liabilities | 10.48M | 8.63% |
Total equity | 7.04M | — |
Shares outstanding | 2.02M | — |
Price to book | 0.64 | — |
Return on assets | -18.84% | — |
Return on capital | -27.65% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -1.19M | 39.98% |
Cash from operations | -1.24M | -12.11% |
Cash from investing | — | — |
Cash from financing | 3.50M | 3,031.88% |
Net change in cash | 2.26M | 284.23% |
Free cash flow | -952.08K | -177.33% |
Previous close
$2.25
Day range
$2.14 - $2.61
Year range
$2.14 - $12.32
Market cap
3.61M USD
Avg Volume
24.26K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2007
Headquarters
Website
Employees
3
